Interestingly, secreted ERdj3 has also been identified as a potential biomarker for nephrotic syndrome, suggesting potential diagnostic benefits for ER stress–dependent increases in ERdj3 secretion (Tousson-Abouelazm et al., 2020; Li and Chen, 2021). The gene discussed is DNAJB11; the disease is nephrotic syndrome.